LifeStance Health (LFST) - 2025 Q3 - Earnings Call Presentation

Financial Performance - Q3 2025 revenue reached $363.8 million, a 16% year-over-year increase[10, 12] - Center Margin for Q3 2025 was $116.6 million, representing 32.0% of revenue[10, 12] - Adjusted EBITDA for Q3 2025 was $40.2 million, or 11.1% of revenue[10, 12] Operational Metrics - Total clinicians increased to 7,996, an 11% year-over-year growth, with 288 net clinician additions in Q3[10, 12] - Q3 2025 visit volumes totaled 2.3 million, a 17% year-over-year increase[10] - The company ended Q3 with a cash position of $203.9 million[10] Guidance - The company reaffirmed its FY 2025 revenue guidance midpoint of $1.41 billion - $1.43 billion[20] - The company raised its FY 2025 Center Margin guidance from $441-$465 million to $448-$462 million[20] - The company raised its FY 2025 Adjusted EBITDA guidance from $140-$150 million to $146-$152 million[20]